Cargando…
Homocysteine Plasmatic Concentration in Brain-Injured Neurocritical Care Patients: Systematic Review of Clinical Evidence
Background: Hyperhomocysteinemia (HHcy) is considered as an independent risk factor for several diseases, such as cardiovascular, neurological and autoimmune conditions. Atherothrombotic events, as a result of endothelial dysfunction and increased inflammation, are the main mechanisms involved in va...
Autores principales: | Lauretta, Maria Paola, Melotti, Rita Maria, Sangermano, Corinne, George, Anneliya Maria, Badenes, Rafael, Bilotta, Federico |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780007/ https://www.ncbi.nlm.nih.gov/pubmed/35054087 http://dx.doi.org/10.3390/jcm11020394 |
Ejemplares similares
-
Optimal glycemic control in neurocritical care patients
por: Bilotta, Federico, et al.
Publicado: (2012) -
Plasmatic higher levels of homocysteine in Non-alcoholic fatty liver disease (NAFLD)
por: de Carvalho, Sylene Coutinho Rampche, et al.
Publicado: (2013) -
Mechanical ventilation and neurocritical patients: is there a role for anti-neuroinflammatory therapies?
por: Giordano, Giovanni, et al.
Publicado: (2020) -
Total homocysteine plasmatic levels as a marker of clinical severity in septic patients
por: Coelho Neto, AA, et al.
Publicado: (2003) -
Total homocysteine plasmatic levels as a marker of clinical severity in septic patients
por: Coelho Neto, AA, et al.
Publicado: (2005)